Filing Details
- Accession Number:
- 0001245261-10-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-19 13:00:00
- Reporting Period:
- 2010-05-17
- Filing Date:
- 2010-05-19
- Accepted Time:
- 2010-05-19 20:15:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069530 | Pain Therapeutics Inc | PTIE | Pharmaceutical Preparations (2834) | 911911336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1252240 | Grant Schoenhard | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-17 | 1,500 | $4.40 | 49,687 | No | 4 | X | Direct | |
| Common Stock | Acquisiton | 2010-05-17 | 3,609 | $5.25 | 53,296 | No | 4 | X | Direct | |
| Common Stock | Acquisiton | 2010-05-18 | 7,926 | $5.25 | 61,222 | No | 4 | X | Direct | |
| Common Stock | Disposition | 2010-05-17 | 5,109 | $5.75 | 5,611 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-05-18 | 7,926 | $5.78 | 48,187 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock | Acquisiton | 2010-05-17 | 1,500 | $4.40 | 1,500 | $4.40 |
| Common Stock | Common Stock | Acquisiton | 2010-05-17 | 3,609 | $5.25 | 3,609 | $5.25 |
| Common Stock | Common Stock | Acquisiton | 2010-05-18 | 7,926 | $5.25 | 7,926 | $5.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 682,000 | 2010-01-31 | 2010-07-31 | No | 4 | X | Direct |
| 678,391 | 2009-05-31 | 2015-05-31 | No | 4 | X | Direct |
| 670,465 | 2009-05-31 | 2015-05-31 | No | 4 | X | Direct |
Footnotes
- This sale is made pursuant to a plan intended to comply with rule 10b5-1(c). 5,109 shares of common stock weresold in seven (7) lots at prices ranging from $5.71 to $5.76 per share.
- This sale is made pursuant to a plan intended to comply with rule 10b5-1(c). 7,926 shares of common stock were sold in nine (9) lots at prices ranging from $5.75 to $5.82 per share.
Billionaire Hedge Funds
